Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

OSS vs ZEPP: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

OSS Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 6–3 Matrix Metrics)

OSS Overall Winner 6-Pillar Tally: OSS 4 – 2 ZEPP Matrix Metrics: OSS 6 – 3 ZEPP

As of Nov 20, 2026, One Stop Systems, Inc. (OSS) is the stronger overall head-to-head candidate over Zepp Health Corporation (ZEPP) in the Tradestie Institutional Equity Comparison Engine, winning 6–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). OSS carries a Unified Composite Score of 53.8/100 (HOLD) at $4.01 (42.2x Forward P/E, -2.4% operating margin), whereas ZEPP carries 45.7/100 (HOLD) at $2.31 (3.1x Forward P/E, -12.6% operating margin).

  • Technical & Structure Timing Caution: OSS is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 31.7); meanwhile ZEPP is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 35.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About OSS vs ZEPP
OSS NASDAQ Head-to-Head Winner
One Stop Systems, Inc. Common Stock
Electronic Computers
$4.01
-7.82% 1D
Market Cap $108.9M
TTM Revenue $42M
Forward P/E 42.2x
Beta / 30D Vol 3.95β · 124% Vol
Unified Composite Score
53.8 / 100 HOLD
Tech 43.0 Fund 63.0 Flow 61.0 Mom 64.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -26.2%), weak momentum, RSI 32
RSI-14: 31.7 · SMA20: $4.89 · SMA50: $6.71
ZEPP NYSE
Zepp Health Corporation American depositary shares, each representing sixteen Class A ordinary shares
Electronic Computers
$2.31
-8.33% 1D
Market Cap $37.0M
TTM Revenue $276M
Forward P/E 3.1x
Beta / 30D Vol 2.12β · 68% Vol
Unified Composite Score
45.7 / 100 HOLD
Tech 63.0 Fund 38.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -25.0%), weak momentum, RSI 35
RSI-14: 35.4 · SMA20: $2.40 · SMA50: $3.21

6-Pillar Scorecard Institutional Category Breakdown (OSS 4 – 2 ZEPP)

Columns: Metric · OSS · ZEPP
1. Valuation Multiples ZEPP
Forward P/E 42.2x 3.1x
Trailing P/E 74.1x 3.1x
PEG Ratio N/M N/M
EV / Revenue 2.5x 0.1x
2. Growth & Scale OSS
Revenue Growth (YoY) +35.9% +6.9%
Earnings Growth (YoY) -86.8% -68.1%
TTM Revenue (USD) $42M $276M
Market Cap $108.9M $37.0M
3. Profitability & Quality OSS
Gross Margin 48.1% 38.6%
Operating Margin -2.4% -12.6%
Net Profit Margin 1.0% -15.8%
Return on Equity (ROE) -19.3% -21.2%
4. Balance Sheet & Cash Flow OSS
Cash Generation (TTM) -$14M -$30M EBITDA
Cash Flow Margin -33.3% -11.0% EBITDA Mgn
Net Cash / Leverage $4.3M Net Cash $11.68 Book/Sh · -21.2% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning OSS
Options Structure Phase BREAKDOWN UNCLASSIFIED
Current IV / %ile 89.6% (62nd %ile) 124.3% (94th %ile)
Put/Call OI Skew 3.70x (Put-Skewed) Thin ADR Chain
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat ZEPP
OpEx & R&D Intensity 50.5% of Rev ($21M) 51.2% of Rev ($141M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Computer Hardware Operator Consumer Electronics Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: OSS (6) vs ZEPP (3)
Institutional Metric OSS ZEPP Criterion Row Edge
Market Capitalization
Scale
$108.9M $37.0M Larger Scale OSS
Trailing P/E Ratio
Valuation
74.1x 3.1x Lower Multiple ZEPP
Forward P/E Ratio
Valuation
42.2x 3.1x Lower Multiple ZEPP
Revenue Growth (YoY)
Growth
+35.9% +6.9% Higher Growth OSS
Operating Margin (TTM)
Profitability
-2.4% -12.6% Higher Margin OSS
Net Profit Margin
Profitability
1.0% -15.8% Higher Margin OSS
Return on Equity (ROE)
Capital Efficiency
-19.3% -21.2% Higher ROE OSS
52-Week Range Position
Momentum
1% ($4–$21) 0% ($2–$33) Stronger Trend Tie
Beta / 30D Volatility
Risk Regime
3.95β · 124% Vol 2.12β · 68% Vol Lower Realized Risk ZEPP
Unified Institutional Score
Composite Signal
53.8 / 100 (HOLD) 45.7 / 100 (HOLD) Higher Composite OSS
Trailing 12M Revenue (USD)
Operating Scale
$42M $276M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
48.1% 38.6% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 2.5x EV/Rev N/M PEG · 0.1x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$14M ($4.3M Net Cash) -$30M EBITDA ($11.68 Book/Sh · -21.2% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon ZEPP +18.99 pp
OSS: -32.15% · ZEPP: -13.16%
3M Horizon ZEPP +9.97 pp
OSS: -63.68% · ZEPP: -53.71%
6M Horizon ZEPP +4.31 pp
OSS: -77.51% · ZEPP: -73.2%
1Y Horizon OSS +79.11 pp
OSS: -11.28% · ZEPP: -90.39%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on OSS vs ZEPP. Trailing 12-month operating profitability (OSS -2.4% vs ZEPP -12.6%) and valuation multiples (OSS 42.2x vs ZEPP 3.1x Forward P/E) are benchmarked directly in Pillar 4 below.

OSS ADR TTM Benchmark FX-Normalized USD
TTM Revenue$42M
Gross Margin48.1%
Op. Margin-2.4%
ROE / Fwd P/E-19.3% · 42.2x
ZEPP ADR TTM Benchmark FX-Normalized USD
TTM Revenue$276M
Gross Margin38.6%
Op. Margin-12.6%
ROE / Fwd P/E-21.2% · 3.1x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
OSS BREAKDOWN
120d in phase · OBV NEUTRAL
Current IV 89.6%
IV Percentile 62nd %ile
Put/Call OI Skew 3.70x (Put-Skewed)
IV Regime Elevated (60th–80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BEARISH
OBV Flow NEUTRAL
Exact OSS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ZEPP UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 124.3%
IV Percentile 94th %ile
Put/Call OI Skew Thin ADR Chain
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ZEPP Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
OSS Moat Profile Cyclical / Execution-Driven Positioning
Computer Hardware Operator
Competes within the Computer Hardware value chain with $108.9M market capitalization and -2.4% operating margin.
OpEx & R&D Reinvestment 50.5% of Rev ($21M)
90D Engineering Disclosures 0 Published
ZEPP Moat Profile Cyclical / Execution-Driven Positioning
Consumer Electronics Operator
Competes within the Consumer Electronics value chain with $37.0M market capitalization and -12.6% operating margin.
OpEx & R&D Reinvestment 51.2% of Rev ($141M)
90D Engineering Disclosures 0 Published

Investor FAQ OSS vs ZEPP Key Questions & Quantitative Answers

As of Nov 20, 2026, One Stop Systems, Inc. (OSS) is the stronger overall head-to-head candidate over Zepp Health Corporation (ZEPP) in the Tradestie Institutional Equity Comparison Engine, winning 6–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). OSS carries a Unified Composite Score of 53.8/100 (HOLD) at $4.01 (42.2x Forward P/E, -2.4% operating margin), whereas ZEPP carries 45.7/100 (HOLD) at $2.31 (3.1x Forward P/E, -12.6% operating margin). Technical & Structure Timing Caution: OSS is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 31.7); meanwhile ZEPP is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 35.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

OSS leads the Growth & Scale pillar: OSS posts +35.9% YoY revenue growth and -86.8% YoY earnings growth on $42M TTM revenue (48.1% gross margin, -2.4% operating margin), compared with ZEPP at +6.9% YoY revenue growth and -68.1% YoY earnings growth on $276M TTM revenue (38.6% gross margin, -12.6% operating margin). On trailing 12-month operating scale, OSS generates $42M in USD-normalized revenue versus $276M for ZEPP. In operating R&D and SG&A reinvestment, OSS deploys 50.5% of Rev ($21M) (0 90-day corporate R&D disclosures) versus 51.2% of Rev ($141M) (0 disclosures) for ZEPP.

ZEPP screens cheaper on headline valuation multiples. OSS trades at 42.2x Forward P/E, 74.1x Trailing P/E, N/M PEG, and 2.5x EV/Revenue (-33.3% FCF margin), whereas ZEPP trades at 3.1x Forward P/E, 3.1x Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-11.0% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against OSS (-19.3% ROE) versus ZEPP (-21.2% ROE) capital efficiency.

In options market volatility and institutional positioning, OSS carries 89.6% implied volatility (62nd %ile, Elevated (60th–80th %ile)), a 3.70x (Put-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (3.95β · 124% Vol realized risk). By comparison, ZEPP carries 124.3% implied volatility (94th %ile, Extreme (>80th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.12β · 68% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Zepp Health Corporation American depositary shares, each representing sixteen Class A ordinary shares (ZEPP) Research Suite

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.